MYMD
Price:
$1.81
Market Cap:
$6.38M
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is a...[Read more]
Industry
Biotechnology
IPO Date
2014-01-23
Stock Exchange
NASDAQ
Ticker
MYMD
According to MyMD Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.20. This represents a change of -87.37% compared to the average of -1.55 of the last 4 quarters.
The mean historical PE Ratio of MyMD Pharmaceuticals, Inc. over the last ten years is -0.08. The current -0.20 PE Ratio has changed 24.48% with respect to the historical average. Over the past ten years (40 quarters), MYMD's PE Ratio was at its highest in in the March 2024 quarter at -0.00. The PE Ratio was at its lowest in in the March 2026 quarter at -4.54.
Average
-0.08
Median
-0.00
Minimum
-0.46
Maximum
-0.00
Discovering the peaks and valleys of MyMD Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 13.07%
Maximum Annual PE Ratio = -0.00
Minimum Annual Increase = -52.20%
Minimum Annual PE Ratio = -0.46
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.46 | 13.07% |
| 2024 | -0.00 | -52.20% |
| 2023 | -0.01 | 120.39% |
| 2022 | -0.00 | 118.06% |
| 2021 | -0.00 | 484.07% |
The current PE Ratio of MyMD Pharmaceuticals, Inc. (MYMD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.16
5-year avg
-0.10
10-year avg
-0.08
MyMD Pharmaceuticals, Inc.’s PE Ratio is less than Gamida Cell Ltd. (-0.08), less than Aptose Biosciences Inc. (-0.16), greater than Hillstream BioPharma, Inc. (-0.66), less than Nabriva Therapeutics plc (-0.00), greater than VivoSim Labs, Inc. (-1.05), less than Altamira Therapeutics Ltd. (-0.02), less than Gritstone bio, Inc. (-0.03), less than Onconetix, Inc. (-0.11), less than Unity Biotechnology, Inc. (-0.13), greater than Neuphoria Therapeutics Inc. (-0.32),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.08 | $4.34M | |
| -0.16 | $4.36M | |
| -0.66 | $4.17M | |
| -0.00 | $323.00 | |
| -1.05 | $2.29M | |
| -0.02 | $1.13M | |
| -0.03 | $3.80M | |
| -0.11 | $313.82K | |
| -0.13 | $3.44M | |
| -0.32 | $19.13M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MyMD Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MyMD Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is MyMD Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the highest PE Ratio for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the 3-year average PE Ratio for MyMD Pharmaceuticals, Inc. (MYMD)?
What is the 5-year average PE Ratio for MyMD Pharmaceuticals, Inc. (MYMD)?
How does the current PE Ratio for MyMD Pharmaceuticals, Inc. (MYMD) compare to its historical average?